Novel synthetic dermal fillers based on sodium carboxymethylcellulose: Comparison with crosslinked hyaluronic acid-based dermal fillers

被引:30
作者
不详
机构
[1] FzioMed Inc., San Luis Obispo, CA
[2] FzioMed Inc., San Luis Obispo, CA 93401
关键词
D O I
10.1111/j.1524-4725.2007.33353.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
BACKGROUND The persistence of dermal fillers containing crosslinked hyaluronic acid (XLHA) correlates linearly to the concentration of polymer in solution. For dermal fillers composed of XLHA, a polymer concentration above approximately 25mg/mL is not practical because it cannot be easily injected through a small-bore needle. OBJECTIVE Formulating dermal fillers from mixtures of carboxymethylcellulose (CIVIC) and polyethylene oxide (PEO) has several advantages over XLHA. We hypothesize that increasing the concentration of CMC/PEO will increase the persistence in the dermis. These polymers of CIVIC and PEO can be formulated at higher concentrations than XLHA to produce smooth, particulate-free gels resulting in easier, more controllable injection. Second, these gels are not required to be covalently crosslinked; CMC/PEO forms a stable gel-like structure in solution without crosslinking. MATERIALS AND METHODS Here we have prepared dermal fillers from CMC/PEO polymer blends at concentrations of 20 mg/mL (dermal filler 1), 29 mg/mL (dermal filler 2), 37 mg/mL (dermal filler 3), and 45 mg/mL (dermal filler 4) and measured their rheologic properties compared to commercial XLHA dermal fillers. RESULTS AND CONCLUSIONS The data here demonstrate that it is possible to duplicate the rheologic properties of commercial XLHA fillers using CMC/PEO at different polymer concentrations to formulate improved dermal fillers. All of the dermal filler formulations prepared can be easily injected through 30-gauge needles.
引用
收藏
页码:S136 / S143
页数:8
相关论文
共 15 条
[1]
Andre P, 2005, J Cosmet Laser Ther, V7, P171, DOI 10.1080/14764170500344393
[2]
Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane Perlane and Hylaform, in the treatment of nasolabial folds [J].
Carruthers, A ;
Carey, W ;
De Lorenzi, C ;
Remington, K ;
Schachter, D ;
Sapra, S .
DERMATOLOGIC SURGERY, 2005, 31 (11) :1591-1598
[3]
A COMPARATIVE-STUDY OF THE BIOLOGIC AND IMMUNOLOGICAL RESPONSE TO MEDICAL DEVICES DERIVED FROM DENTAL COLLAGEN [J].
DELUSTRO, F ;
CONDELL, RA ;
NGUYEN, MA ;
MCPHERSON, JM .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1986, 20 (01) :109-120
[4]
FALCONE SJ, IN PRESS BIOMED MA A
[5]
Fernandez Emmy M, 2006, J Drugs Dermatol, V5, P630
[6]
Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation [J].
Friedman, PM ;
Mafong, EA ;
Kauvar, ANB ;
Geronemus, RG .
DERMATOLOGIC SURGERY, 2002, 28 (06) :491-494
[7]
Dermal filler agents: a practical review [J].
Johl, Sukhjit S. ;
Burgett, Richard A. .
CURRENT OPINION IN OPHTHALMOLOGY, 2006, 17 (05) :471-479
[8]
Reliable soft tissue augmentation - A clinical comparison of injectable soft-tissue fillers for facial-volume augmentation [J].
Kanchwala, SK ;
Holloway, L ;
Bucky, LP .
ANNALS OF PLASTIC SURGERY, 2005, 55 (01) :30-35
[9]
PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: Refinements and statistical results [J].
Lemperle, G ;
Gauthier-Hazan, N ;
Lemperle, M .
AESTHETIC PLASTIC SURGERY, 1998, 22 (05) :356-365
[10]
Lowe NJ, 2005, DERMATOL SURG, V31, P1616